Royalty Pharma PLC
RPRX
ISIN GB00BMVP7Y09 / Valor 55041695
Royalty Pharma PLC
UMushroom community rating:
About company
Royalty Pharma PLC is a publicly traded investment company that buys and manages royalty and revenue interests in prescription drugs and biologics, providing upfront capital to drug developers, investors and, occasionally, larger pharmaceutical companies in exchange for a portion of future product sales and milestone payments. It does not conduct drug discovery or commercialization; instead, it builds a diversified portfolio of royalty streams across therapeutic areas and product life cycles and seeks to generate returns from the sales performance of those underlying medicines. The firm funds acquisitions through capital markets and debt, structures bespoke transactions to transfer commercial and development risk, and its revenue profile is directly tied to the commercial success and lifecycle timing of the drugs that underpin its royalty assets.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
25452 M
Market cap (USD)
2,229,485
Daily traded volume (Shares)
25.455 / 25.18
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
